Dr John Marshall puts his vacation on hold to highlight the themes of ASCO 2015, including the critical question: What is value in cancer care, and how much is riding on the correct answer?

Dr Bruce Cheson previews the most important trials being presented at ASCO 2015 on Hodgkin's and non-Hodgkin's lymphoma, acute and chronic leukemia, and multiple myeloma.

When it comes to progression in a patient with EGFR-mutant lung cancer, it's by no means one-size-fits-all. Dr Mark Kris discusses treatment options.

Squamous cell tumors represent 20% of all lung cancers. Dr Mark Kris discusses new approaches to the diagnosis and treatment of these tumors, including nivolumab and ramucirumab.

In a moving story, Dr Eunice Lee reveals how a prenatal genetic test led to a cancer diagnosis and saved her life.

Gerald Chodak comments on a new study that suggests that a baseline low PSA level can save many men the agony of frequent follow-up.

Dr Mark Kris discusses the details of the IMPRESS trial, which assessed the effect of discontinuing gefitinib in patients with EGFR-mutant lung cancer who have developed resistance to the drug.

Eric Topol speaks with singer, songwriter, and oncologic scientist Nazneen Rahman on the importance of understanding the genetics of cancer.

Jimmie Holland, MD, a pioneer of psycho-oncology who was featured in the PBS documentary 'Cancer,' discusses the importance of treating the patient as well as the cancer--and how little time it takes.

Dr Mark Kris recognizes the achievements of the dedicated group of researchers who developed antiemetics, helping to overcome one of the most feared side effects of cancer treatment.